Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy appears in FDA public data with 3 recalls — including 3 Class I (most serious) —, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-1286-2022, Class I) was initiated on June 27, 2022.
Summary
- Total Recalls
- 3 (3 Class I)
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1286-2022 | Class I | Nifedipine WSP 0.2% Ointment, 60 gram tubes, Rx only, Valor Compounding Pharmacy, 2461 Shattuck Ave | June 27, 2022 |
| D-1167-2022 | Class I | Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compo | April 15, 2022 |
| D-1168-2022 | Class I | Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compo | April 15, 2022 |